Compound Evidence File
#EC-2026-0861
Isotretinoin
Filed under Oral Tablets. The bureau holds 39 laboratory returns for this compound from 13 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
13 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 23 May 2026 | 23 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.7 | 7.1 | 10.0 | 24 May 2026 | 24 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 4 | 8.7 | 7.7 | 9.9 | 24 May 2026 | 24 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.3 | 7.5 | 9.6 | 25 May 2026 | 25 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 7 | 8.2 | 6.5 | 9.5 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 7.7 | 6.8 | 8.5 | 21 May 2026 | 21 May 2026 |
| Simple PeptideCASE #VI-2026-0782 | X | 1 | 7.5 | 7.5 | 7.5 | 13 Jun 2025 | 13 Jun 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 6.2 | 6.2 | 6.2 | 27 Feb 2025 | 27 Feb 2025 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 5.0 | 5.0 | 5.0 | 13 Feb 2025 | 13 Feb 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 1 | 4.4 | 4.4 | 4.4 | 13 Jun 2025 | 13 Jun 2025 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 3.4 | 3.4 | 3.4 | 7 May 2025 | 7 May 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 3 Jul 2025 | 3 Jul 2025 |
Open any subject to view the batch-level evidence for Isotretinoin alone.